Development of an in-house 188W/188Re generator

Research output: Contribution to report/book/conference proceedingsIn-proceedings paperpeer-review

Standard

Development of an in-house 188W/188Re generator. / Van de Voorde, Michiel; Burgoyne, Andrew; Ponsard, Bernard; Elema, Dennis; Cardinaels, Thomas; Ooms, Maarten.

European Journal of Nuclear Medicine and Molecular Imaging. Vol. 47 suppl. 1. ed. 2020. p. 477 (European Journal of Nuclear Medicine and Molecular Imaging ; Vol. 47, No. Supplement 1).

Research output: Contribution to report/book/conference proceedingsIn-proceedings paperpeer-review

Harvard

Van de Voorde, M, Burgoyne, A, Ponsard, B, Elema, D, Cardinaels, T & Ooms, M 2020, Development of an in-house 188W/188Re generator. in European Journal of Nuclear Medicine and Molecular Imaging. suppl. 1 edn, vol. 47, European Journal of Nuclear Medicine and Molecular Imaging , no. Supplement 1, vol. 47, pp. 477. https://doi.org/10.1007/s00259-020-04988-4

APA

Van de Voorde, M., Burgoyne, A., Ponsard, B., Elema, D., Cardinaels, T., & Ooms, M. (2020). Development of an in-house 188W/188Re generator. In European Journal of Nuclear Medicine and Molecular Imaging (suppl. 1 ed., Vol. 47, pp. 477). (European Journal of Nuclear Medicine and Molecular Imaging ; Vol. 47, No. Supplement 1). https://doi.org/10.1007/s00259-020-04988-4

Vancouver

Van de Voorde M, Burgoyne A, Ponsard B, Elema D, Cardinaels T, Ooms M. Development of an in-house 188W/188Re generator. In European Journal of Nuclear Medicine and Molecular Imaging. suppl. 1 ed. Vol. 47. 2020. p. 477. (European Journal of Nuclear Medicine and Molecular Imaging ; Supplement 1). https://doi.org/10.1007/s00259-020-04988-4

Author

Van de Voorde, Michiel ; Burgoyne, Andrew ; Ponsard, Bernard ; Elema, Dennis ; Cardinaels, Thomas ; Ooms, Maarten. / Development of an in-house 188W/188Re generator. European Journal of Nuclear Medicine and Molecular Imaging. Vol. 47 suppl. 1. ed. 2020. pp. 477 (European Journal of Nuclear Medicine and Molecular Imaging ; Supplement 1).

Bibtex - Download

@inproceedings{06171645b79b4a66a80d3b31f437fe00,
title = "Development of an in-house 188W/188Re generator",
abstract = "188Re decays by emitting high-energy beta particles (Emax: 2.1 MeV, Eav: 784 keV), which can be used to kill targeted tumor cells. The short half-life (t1/2 = 16.9 h) of 188Re allows it to be used in targeted radionuclide therapy when linked to peptides or antibodies. 188Re decays with a 155 keV (15%) gamma emission suitable for imaging and dosimetry. Combining these properties make 188Re an ideal theranostic agent in clinical nuclear medicine. Furthermore, 188Re is readily available from a 188W/188Re generator which enables the use of nca 188Re in hospitals and remote locations [1].",
keywords = "188W/188Re generator, radiolabeling, chelator, in house",
author = "{Van de Voorde}, Michiel and Andrew Burgoyne and Bernard Ponsard and Dennis Elema and Thomas Cardinaels and Maarten Ooms",
note = "Score=3",
year = "2020",
month = oct,
day = "30",
doi = "10.1007/s00259-020-04988-4",
language = "English",
volume = "47",
series = "European Journal of Nuclear Medicine and Molecular Imaging ",
publisher = "Springer",
number = "Supplement 1",
pages = "477",
booktitle = "European Journal of Nuclear Medicine and Molecular Imaging",
edition = "suppl. 1",

}

RIS - Download

TY - GEN

T1 - Development of an in-house 188W/188Re generator

AU - Van de Voorde, Michiel

AU - Burgoyne, Andrew

AU - Ponsard, Bernard

AU - Elema, Dennis

AU - Cardinaels, Thomas

AU - Ooms, Maarten

N1 - Score=3

PY - 2020/10/30

Y1 - 2020/10/30

N2 - 188Re decays by emitting high-energy beta particles (Emax: 2.1 MeV, Eav: 784 keV), which can be used to kill targeted tumor cells. The short half-life (t1/2 = 16.9 h) of 188Re allows it to be used in targeted radionuclide therapy when linked to peptides or antibodies. 188Re decays with a 155 keV (15%) gamma emission suitable for imaging and dosimetry. Combining these properties make 188Re an ideal theranostic agent in clinical nuclear medicine. Furthermore, 188Re is readily available from a 188W/188Re generator which enables the use of nca 188Re in hospitals and remote locations [1].

AB - 188Re decays by emitting high-energy beta particles (Emax: 2.1 MeV, Eav: 784 keV), which can be used to kill targeted tumor cells. The short half-life (t1/2 = 16.9 h) of 188Re allows it to be used in targeted radionuclide therapy when linked to peptides or antibodies. 188Re decays with a 155 keV (15%) gamma emission suitable for imaging and dosimetry. Combining these properties make 188Re an ideal theranostic agent in clinical nuclear medicine. Furthermore, 188Re is readily available from a 188W/188Re generator which enables the use of nca 188Re in hospitals and remote locations [1].

KW - 188W/188Re generator

KW - radiolabeling

KW - chelator

KW - in house

UR - https://ecm.sckcen.be/OTCS/llisapi.dll/open/42349904

U2 - 10.1007/s00259-020-04988-4

DO - 10.1007/s00259-020-04988-4

M3 - In-proceedings paper

VL - 47

T3 - European Journal of Nuclear Medicine and Molecular Imaging

SP - 477

BT - European Journal of Nuclear Medicine and Molecular Imaging

ER -

ID: 7071702